Optec International, Inc. (OPTI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2721 LOKER AVENUE WEST CARLSBAD, CA 92010 |
| State of Incorp. | WY |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 0 | 9 | 33 | |||
| Cash and cash equivalents | 0 | 9 | 33 | |||
| Receivables | 5 | |||||
| Inventory, net of allowances, customer advances and progress billings | ||||||
| Inventory | ||||||
| Prepaid expense | ||||||
| Total current assets: | 5 | 9 | 33 | |||
| Noncurrent Assets | ||||||
| Intangible assets, net (including goodwill) | 2 | 4 | 8 | |||
| Intangible assets, net (excluding goodwill) | 2 | 4 | 8 | |||
| Other undisclosed noncurrent assets | 11 | 13 | 13 | |||
| Total noncurrent assets: | 13 | 17 | 21 | |||
| TOTAL ASSETS: | 18 | 26 | 54 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 7 | 5 | ||||
| Interest and dividends payable | ||||||
| Accounts payable | 7 | 5 | ||||
| Other undisclosed accounts payable and accrued liabilities | ||||||
| Debt | ||||||
| Due to related parties | ||||||
| Other undisclosed current liabilities | ||||||
| Total current liabilities: | 7 | 5 | ||||
| Noncurrent Liabilities | ||||||
| Total liabilities: | 7 | 5 | ||||
| Equity | ||||||
| Equity, attributable to parent, including: | 11 | 21 | 54 | |||
| Common stock | 53 | 53 | ||||
| Additional paid in capital | 1 | 1 | 1 | |||
| Retained earnings (accumulated deficit) | (43) | (33) | 0 | |||
| Other undisclosed equity, attributable to parent | 53 | |||||
| Total equity: | 11 | 21 | 54 | |||
| Other undisclosed liabilities and equity | 0 | |||||
| TOTAL LIABILITIES AND EQUITY: | 18 | 26 | 54 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | ||
|---|---|---|---|---|---|
| Revenues | 24 | 31 | |||
| Revenue, net | 24 | 31 | |||
| Cost of revenue | (7) | (11) | (50) | ||
| Cost of goods and services sold | (7) | (11) | |||
| Other undisclosed gross profit | (1) | ||||
| Gross profit: | 17 | 19 | (50) | ||
| Operating expenses | (27) | (52) | (6) | ||
| Operating loss: | (10) | (33) | (56) | ||
| Interest and debt expense | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | |||||
| Loss from continuing operations before income taxes: | (10) | (33) | (56) | ||
| Income tax expense | (5) | ||||
| Loss from continuing operations: | (10) | (38) | (56) | ||
| Loss before gain (loss) on sale of properties: | (10) | (38) | (56) | ||
| Other undisclosed net income | 5 | ||||
| Net loss: | (10) | (33) | (56) | ||
| Other undisclosed net income (loss) attributable to parent | 45 | ||||
| Net loss available to common stockholders, diluted: | (10) | (33) | (11) | ||
Comprehensive Income ($ in thousands)
| 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | ||
|---|---|---|---|---|---|
| Net loss: | (10) | (33) | (56) | ||
| Comprehensive loss, net of tax, attributable to parent: | (10) | (33) | (56) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.